Marc Coleman Comment On Regulatory Notice 22-08 Marc Coleman N/A There is no reason to treat inverse and leveraged ETFs different than any other investment. All investments have risk and the individual needs to do their own research.
Marc Coleman Comment On Regulatory Notice 22-08
There is no reason to treat inverse and leveraged ETFs different than any other investment. All investments have risk and the individual needs to do their own research.